Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Goodwill (2016 - 2025)

Historic Goodwill for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $13.9 million.

  • Lifecore Biomedical, Inc. \De\'s Goodwill changed 0.0% to $13.9 million in Q2 2025 from the same period last year, while for May 2025 it was $13.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $13.9 million for FY2025, which is 0.0% changed from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Goodwill stood at $13.9 million for Q2 2025, which was down 0.0% from $13.9 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s Goodwill's 5-year high stood at $13.9 million during Q2 2022, with a 5-year trough of $13.9 million in Q1 2021.
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Goodwill averaged around $13.9 million, with its median value being $13.9 million (2021).
  • Its Goodwill has fluctuated over the past 5 years, first tumbled by 8203.01% in 2021, then rose by 13.69% in 2022.
  • Lifecore Biomedical, Inc. \De\'s Goodwill (Quarter) stood at $13.9 million in 2021, then changed by 0.0% to $13.9 million in 2022, then changed by 0.0% to $13.9 million in 2023, then changed by 0.0% to $13.9 million in 2024, then changed by 0.0% to $13.9 million in 2025.
  • Its last three reported values are $13.9 million in Q2 2025, $13.9 million for Q1 2025, and $13.9 million during Q4 2024.